In order to examine the contribution of truncated forms of TDP-43 to motor or cognitive decline in ALS and FTD, several transgenic rodent models expressing TDP-43 CTFs of approximately 25 kDa have been developed. This evidence concerns the gene TARDBP and frontotemporal dementia.